MedTrace Logo

Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

NCT04449406 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2026-04-07

No results posted yet for this study

Summary

Urine and blood samples are being collected from patients with and without diseases of the pancreas. These samples will be tested with the aim of developing an accurate way of diagnosing diseases of the pancreas using the results.

Conditions

Sponsors & Collaborators

  • University of Liverpool

    collaborator OTHER

  • University College, London

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Pancreatic Cancer Research Fund

    collaborator UNKNOWN

  • Ospedale San Raffaele

    collaborator OTHER

  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Tatjana Crnogorac-Jurcevic, MD, PhD · Queen Mary University of London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04449406 on ClinicalTrials.gov